149 related articles for article (PubMed ID: 31359126)
1. Strain elastography as an early predictor of long-term prognosis in patients with locally advanced cervical cancers treated with concurrent chemoradiotherapy.
Xu Y; Zhu L; Zhu L; Wang H; Ru T; Liu B; He J; Tian S; Zhou Z; Yang X
Eur Radiol; 2020 Jan; 30(1):471-481. PubMed ID: 31359126
[TBL] [Abstract][Full Text] [Related]
2. Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.
Xu Y; Zhu L; Liu B; Ru T; Wang H; He J; Liu S; Yang X; Zhou Z; Liu T
BMC Cancer; 2017 Jun; 17(1):427. PubMed ID: 28629386
[TBL] [Abstract][Full Text] [Related]
3. Predicting and Early Monitoring Treatment Efficiency of Cervical Cancer Under Concurrent Chemoradiotherapy by Intravoxel Incoherent Motion Magnetic Resonance Imaging.
Zhu L; Zhu L; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X
J Comput Assist Tomogr; 2017; 41(3):422-429. PubMed ID: 27824669
[TBL] [Abstract][Full Text] [Related]
4. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
Xu C; Sun H; Du S; Xin J
Eur J Radiol; 2019 Aug; 117():1-8. PubMed ID: 31307633
[TBL] [Abstract][Full Text] [Related]
5. Predictive and prognostic value of intravoxel incoherent motion (IVIM) MR imaging in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
Zhu L; Wang H; Zhu L; Meng J; Xu Y; Liu B; Chen W; He J; Zhou Z; Yang X
Sci Rep; 2017 Sep; 7(1):11635. PubMed ID: 28912536
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy.
Gu KW; Kim CK; Choi CH; Yoon YC; Park W
Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of diffusion-weighted magnetic resonance imaging and
Park JJ; Kim CK; Park BK
Radiother Oncol; 2016 Sep; 120(3):507-511. PubMed ID: 26900089
[TBL] [Abstract][Full Text] [Related]
10. Texture Analysis as Imaging Biomarker for recurrence in advanced cervical cancer treated with CCRT.
Meng J; Liu S; Zhu L; Zhu L; Wang H; Xie L; Guan Y; He J; Yang X; Zhou Z
Sci Rep; 2018 Jul; 8(1):11399. PubMed ID: 30061666
[TBL] [Abstract][Full Text] [Related]
11. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy.
Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X
Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177
[TBL] [Abstract][Full Text] [Related]
12. Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.
Zhu L; Zhu L; Shi H; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X; Liu T
BMC Cancer; 2016 Feb; 16():79. PubMed ID: 26860361
[TBL] [Abstract][Full Text] [Related]
13. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
Bae JM; Kim CK; Park JJ; Park BK
Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
Gao S; Du S; Lu Z; Xin J; Gao S; Sun H
Eur Radiol; 2020 Feb; 30(2):1191-1201. PubMed ID: 31493211
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
Son SH; Jeong SY; Chong GO; Lee YH; Park SH; Lee CH; Hong CM; Jeong JH; Lee SW; Ahn BC; Lee J
Clin Nucl Med; 2018 Sep; 43(9):e296-e303. PubMed ID: 30036243
[TBL] [Abstract][Full Text] [Related]
16. Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: value of post-treatment diffusion-weighted imaging.
Park JJ; Kim CK; Park BK
Eur Radiol; 2016 Sep; 26(9):3272-9. PubMed ID: 26685853
[TBL] [Abstract][Full Text] [Related]
17. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
[TBL] [Abstract][Full Text] [Related]
18. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
[TBL] [Abstract][Full Text] [Related]
19. Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
Perucho JAU; Wang M; Tse KY; Ip PPC; Siu SWK; Ngan HYS; Khong PL; Lee EYP
Eur Radiol; 2021 Mar; 31(3):1727-1735. PubMed ID: 32885298
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Short-Term Imaging and Squamous Cell Carcinoma Antigen to Early Predict Response to Concurrent Chemoradiotherapy in Patients With Cervical Cancer.
Yoo JG; Kim SI; Yeo SG; Park DC
Cancer Control; 2022; 29():10732748221074530. PubMed ID: 35196888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
